Multiplex Biomarker Imaging Market - Global Industry Analysis

Brand: Zion Market Research
SKU: ZMR-1670
Price: 4199.00 USD
Availability: InStock
Rating: 4.4 (89 reviews)

Multiplex Biomarker Imaging Market by Application (Drug Safety, Oncology Studies, and Genetic Characterization Studies), by Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent in the Situ Hybridization (FISH) Assay, and Toponome Imaging System (TIS)), and by End-User (Research Institutes Government & Private, Clinical Labs, and Pharmaceutical & Biotechnology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Published Date: 12-Sep-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-1670 Status : Published

Global multiplex biomarker imaging market expected to generate revenue of around USD 608.2 million by end of 2024, growing at a CAGR of around 12.3% between 2018 and 2024. Increasing demand for analysis of the diseases and imaging has accelerated the growth of the multiplex biomarker imaging market over the estimated time.

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

The report covers forecast and analysis for the multiplex biomarker imaging market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the multiplex biomarker imaging market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the multiplex biomarker imaging market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the multiplex biomarker imaging market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein application, imaging techniques, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Multiplex Biomarker Imaging Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view of the multiplex biomarker imaging market by segmenting the market based on application, imaging techniques, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.

Global multiplex biomarker imaging market is divided into its application, imaging techniques, and end-user. On the basis of the application, the market is divided into drug safety, oncology studies, and genetic characterization studies.

Based on imaging techniques multiplex biomarker imaging market is categorized into immunofluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in the situ hybridization (FISH) assay, and toponome imaging system (TIS).

On the basis of the end user, the multiplex biomarker imaging market is segregated as research institutes government & private, clinical labs, and pharmaceutical & biotechnology.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for multiplex biomarker imaging based on individual segment and application in all the regions and countries.

The report also includes detailed profiles of end players such as Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., and others.

This report segments the global multiplex biomarker imaging market as follows:

Global Multiplex Biomarker Imaging Market: By Application

Drug Safety
Oncology Studies
Genetic Characterization Studies

Global Multiplex Biomarker Imaging Market: By Imaging Techniques

Immuno Fluorescence (IF) Assay
Tissue Microarray (TMA) Assay
Immunohistochemistry (IHC) Assay
Fluorescent in the Situ Hybridization (FISH) Assay
Toponome Imaging System (TIS)

Global Multiplex Biomarker Imaging Market: By End User

Research Institutes Government & Private
Clinical Labs
Pharmaceutical & Biotechnology

Global Multiplex Biomarker Imaging Market: By Region

North America
- The U.S.
Europe
- UK
- France
- Germany
Asia Pacific
- China
- Japan
- India
Latin America
- Brazil
The Middle East and Africa

Table Of Content

Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
  - 1.3.1. Market research process
  - 1.3.2. Market research methodology
Chapter 2. Executive Summary
- 2.1. Global multiplex biomarker imaging market, 2015 - 2024 (USD Million)
- 2.2. Global multiplex biomarker imaging market : Snapshot
Chapter 3. Global Multiplex Biomarker Imaging- Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
  - 3.2.1. Global multiplex biomarker imaging market drivers: Impact analysis
  - 3.2.2. Increasing cancer and tumor-related cases
  - 3.2.3. Cost effective in nature
  - 3.2.4. Provides better results of the analysis which includes thousands of tissue in the single turn
- 3.3. Market Restraints
  - 3.3.1. Stringent policies of the government
  - 3.3.2. Complex process
  - 3.3.3. Ethical issue
- 3.4. Opportunities
  - 3.4.1. Technique that has the potential for the anticancer drug discovery
  - 3.4.2. Growing healthcare end-user offers huge potential for multiplex biomarker imaging
- 3.5. Porter's five forces analysis
  - 3.5.1. Bargaining power of suppliers
  - 3.5.2. Bargaining power of buyers
  - 3.5.3. Threat from new entrants
  - 3.5.4. Threat from new substitutes
  - 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
  - 3.6.1. Market attractiveness analysis, by application
  - 3.6.2. Market attractiveness analysis, by imaging techniques
  - 3.6.3. Market attractiveness analysis, by end use
Chapter 4. Global Multiplex Biomarker Imaging Market - Competitive Landscape
- 4.1. Company market share analysis
  - 4.1.1. Global multiplex biomarker imaging market: company market share, 2015
- 4.2. Strategic Development
  - 4.2.1. Acquisitions & Mergers
  - 4.2.2. New Product Launch
  - 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
  - 4.2.4. Research and Development, Regional Expansion
Chapter 5. Global Multiplex Biomarker Imaging Market - Application Segment Analysis
- 5.1. Global multiplex biomarker imaging market: application overview
  - 5.1.1. Global multiplex biomarker imaging market revenue share, by application, 2018 and 2024
- 5.2. Drug Safety
  - 5.2.1. Global multiplex biomarker imaging market for drug safety, 2015 - 2024 (USD Million)
- 5.3. Oncology Studies
  - 5.3.1. Global multiplex biomarker imaging market for oncology studies, 2015 - 2024 (USD Million)
- 5.4. Genetic Characterization Studies
  - 5.4.1. Global multiplex biomarker imaging market for genetic characterization studies, 2015 - 2024 (USD Million)
Chapter 6. Global Multiplex Biomarker Imaging Market - Imaging Techniques Segment Analysis
- 6.1. Global multiplex biomarker imaging market: imaging techniques overview
  - 6.1.1. Global multiplex biomarker imaging market revenue share, by imaging techniques, 2018 and 2024
- 6.2. Immuno Fluorescence (IF) Assay
  - 6.2.1. Global multiplex biomarker imaging market for immunofluorescence (IF) assay, 2015 - 2024 (USD Million)
- 6.3. Tissue Microarray (TMA) Assay
  - 6.3.1. Global multiplex biomarker imaging market for tissue microarray (TMA) assay, 2015 - 2024 (USD Million)
- 6.4. Immunohistochemistry (IHC) Assay
  - 6.4.1. Global multiplex biomarker imaging market for immunohistochemistry (IHC) assay, 2015 - 2024 (USD Million)
- 6.5. Fluorescent in the Situ Hybridization (FISH) Assay
  - 6.5.1. Global multiplex biomarker imaging market for fluorescent in the situ hybridization (fish) assay, 2015 - 2024 (USD Million)
- 6.6. Toponome Imaging System (TIS)
  - 6.6.1. Global multiplex biomarker imaging market toponome imaging system (TIS), 2015 - 2024 (USD Million)
Chapter 7. Global Multiplex Biomarker Imaging Market - End-User Segment Analysis
- 7.1. Global multiplex biomarker imaging market: End User overview
  - 7.1.1. Global multiplex biomarker imaging market revenue share, by end user, 2018 and 2024
- 7.2. Research Institutes Government & Private
  - 7.2.1. Global multiplex biomarker imaging market for research institutes government & private, 2015 - 2024 (USD Million)
- 7.3. Clinical Labs
  - 7.3.1. Global multiplex biomarker imaging market for clinical labs , 2015 - 2024 (USD Million)
- 7.4. Pharmaceutical & Biotechnology
  - 7.4.1. Global multiplex biomarker imaging market for pharmaceutical & biotechnology, 2015 - 2024 (USD Million)
Chapter 8. Global Multiplex Biomarker Imaging Market - Regional Segment Analysis
- 8.1. Global multiplex biomarker imaging market: regional overview
  - 8.1.1. Global multiplex biomarker imaging market revenue share, by region, 2018 and 2024
  - 8.1.2. North America
    - 8.1.2.1. North America multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.1.2.2. North America multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.1.2.3. North America multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.1.3. The U.S.
    - 8.1.3.1. The U.S. multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.1.3.2. The U.S. multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.1.3.3. The U.S. multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.1.4. Canada
    - 8.1.4.1. Canada multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.1.4.2. Canada multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.1.4.3. Canada multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
- 8.2. Europe
  - 8.2.1. Europe multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
  - 8.2.2. Europe multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
  - 8.2.3. Europe multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.2.4. U.K.
    - 8.2.4.1. U.K. multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.2.4.2. U.K. multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.2.4.3. U.K. multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.2.5. Germany
    - 8.2.5.1. Germany multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.2.5.2. Germany multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.2.5.3. Germany multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.2.6. France
    - 8.2.6.1. France multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.2.6.2. France multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.2.6.3. France multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.2.7. Rest of Europe
    - 8.2.7.1. Rest of Europe multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.2.7.2. Rest of Europe multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.2.7.3. Rest of Europe multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
- 8.3. Asia Pacific
  - 8.3.1. Asia Pacific multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
  - 8.3.2. Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
  - 8.3.3. Asia Pacific multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.3.4. China
    - 8.3.4.1. China multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.3.4.2. China multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.3.4.3. China multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.3.5. Japan
    - 8.3.5.1. Japan multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.3.5.2. Japan multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.3.5.3. Japan multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.3.6. India
    - 8.3.6.1. India multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.3.6.2. India multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.3.6.3. India multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.3.7. Rest of Asia Pacific
    - 8.3.7.1. Rest of Asia Pacific multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.3.7.2. Rest of Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.3.7.3. Rest of Asia Pacific multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
- 8.4. Latin America
  - 8.4.1. Latin America multiplex biomarker imaging market revenue, by application, 2015 - 2024(USD Million)
  - 8.4.2. Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
  - 8.4.3. Latin America multiplex biomarker imaging market revenue, by end user, 2015 - 2024(USD Million)
  - 8.4.4. Brazil
    - 8.4.4.1. Brazil multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.4.4.2. Brazil multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.4.4.3. Brazil multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  - 8.4.5. Rest of Latin America
    - 8.4.5.1. Rest of Latin America multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
    - 8.4.5.2. Rest of Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
    - 8.4.5.3. Rest of Latin America multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
- 8.5. The Middle East and Africa
  - 8.5.1. The Middle East and Africa multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
  - 8.5.2. The Middle East and Africa multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
  - 8.5.3. The Middle East and Africa multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
Chapter 9. Company Profile
- 9.1. Thermo Fisher Scientific
  - 9.1.1. Overview
  - 9.1.2. Financials
  - 9.1.3. Product portfolio
  - 9.1.4. Business strategy
  - 9.1.5. Recent developments
- 9.2. PerkinElmer Inc.
  - 9.2.1. Overview
  - 9.2.2. Financials
  - 9.2.3. Product portfolio
  - 9.2.4. Business strategy
  - 9.2.5. Recent developments
- 9.3. Bio-Rad Laboratories, Inc.
  - 9.3.1. Overview
  - 9.3.2. Financials
  - 9.3.3. Product portfolio
  - 9.3.4. Business strategy
  - 9.3.5. Recent developments
- 9.4. Abcam Plc.,
  - 9.4.1. Overview
  - 9.4.2. Financials
  - 9.4.3. Product portfolio
  - 9.4.4. Business strategy
  - 9.4.5. Recent developments
- 9.5. US Biomax Inc.
  - 9.5.1. Overview
  - 9.5.2. Financials
  - 9.5.3. Product portfolio
  - 9.5.4. Business strategy
  - 9.5.5. Recent developments
- 9.6. Merck KGaA
  - 9.6.1. Overview
  - 9.6.2. Financials
  - 9.6.3. Product portfolio
  - 9.6.4. Business strategy
  - 9.6.5. Recent developments
- 9.7. ToposNomos Ltd.
  - 9.7.1. Overview
  - 9.7.2. Financials
  - 9.7.3. Product portfolio
  - 9.7.4. Business strategy
  - 9.7.5. Recent developments
- 9.8. MicroConstants, Inc.
  - 9.8.1. Overview
  - 9.8.2. Financials
  - 9.8.3. Product portfolio
  - 9.8.4. Business strategy
  - 9.8.5. Recent developments
- 9.9. Aushon BioSystems Ltd.
  - 9.9.1. Overview
  - 9.9.2. Financials
  - 9.9.3. Product portfolio
  - 9.9.4. Business strategy
  - 9.9.5. Recent developments
- 9.10. Ventana Medical Systems, Inc.
  - 9.10.1. Overview
  - 9.10.2. Financials
  - 9.10.3. Product portfolio
  - 9.10.4. Business strategy
  - 9.10.5. Recent developments
- 9.11. Leica Biosystems Nussloch GmbH
  - 9.11.1. Overview
  - 9.11.2. Financials
  - 9.11.3. Product portfolio
  - 9.11.4. Business strategy
  - 9.11.5. Recent developments
- 9.12. Illumina Inc.
  - 9.12.1. Overview
  - 9.12.2. Financials
  - 9.12.3. Product portfolio
  - 9.12.4. Business strategy
  - 9.12.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global multiplex biomarker imaging market revenue, 2015 – 2024 (USD Million)
4. Porter’s five forces analysis
5. Global multiplex biomarker imaging market attractiveness analysis, by application
6. Global multiplex biomarker imaging market attractiveness analysis, by imaging techniques
7. Global multiplex biomarker imaging: market attractiveness analysis, by end user
8. Global multiplex biomarker imaging: market attractiveness analysis, by regional segment
9. Company market share analysis, 2018
10. Global multiplex biomarker imaging market revenue share by application, 2018 and 2024
11. Global multiplex biomarker imaging market for drug safety, 2015 – 2024 (USD Million)
12. Global multiplex biomarker imaging market for oncology studies, 2015 – 2024 (USD Million)
13. Global multiplex biomarker imaging market for genetic characterization studies, 2015 – 2024 (USD Million)
14. Global multiplex biomarker imaging market revenue share by imaging techniques, 2018 and 2024
15. Global multiplex biomarker imaging market for immuno fluorescence (IF) assay, 2015 – 2024 (USD Million)
16. Global multiplex biomarker imaging market for tissue microarray (TMA) assay , 2015 – 2024 (USD Million)
17. Global multiplex biomarker imaging market for immunohistochemistry (IHC) assay, 2015 – 2024 (USD Million)
18. Global multiplex biomarker imaging market for fluorescent in the situ hybridization (FISH) assay, 2015 – 2024 (USD Million)
19. Global multiplex biomarker imaging market for toponome imaging system (TIS), 2015 – 2024 (USD Million)
20. Global multiplex biomarker imaging market revenue share by end user, 2018 and 2024
21. Global multiplex biomarker imaging market for research institutes government & private , 2015 – 2024 (USD Million)
22. Global multiplex biomarker imaging market for clinical labs , 2015 – 2024 (USD Million)
23. Global multiplex biomarker imaging market for pharmaceutical & biotechnology, 2015 – 2024 (USD Million)
24. North America multiplex biomarker imaging market, 2015 - 2024 (USD Million)
25. Europe multiplex biomarker imaging market, 2015 - 2024 (USD Million)
26. Asia Pacific multiplex biomarker imaging market, 2015 - 2024 (USD Million)
27. Latin America multiplex biomarker imaging market, 2015 - 2024 (USD Million)
28. The Middle East and Africa multiplex biomarker imaging market, 2015 - 2024 (USD Million)

Table Of Tables

List of Tables

1. Multiplex biomarker imaging market: market snapshot
2. Drivers of global multiplex biomarker imaging market: impact analysis
3. Restraints of global multiplex biomarker imaging market: impact analysis
4. North America multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
5. North America multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
6. North America multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
7. The U.S. multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
8. The U.S. multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
9. The U.S. multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
10. Canada multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
11. Canada multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
12. Canada multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
13. Europe multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
14. Europe multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
15. Europe multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
16. U.K. multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
17. U.K. multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
18. U.K. multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
19. Germany multiplex biomarker imaging market revenue, by application, 2015 – 2024
20. Germany multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
21. Germany multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
22. France multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
23. France multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
24. France multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
25. Rest of Europe multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
26. Rest of Europe multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
27. Rest of Europe multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
28. Asia Pacific multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
29. Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
30. Asia Pacific multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
31. China multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
32. China multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
33. China multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
34. Japan multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
35. Japan multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
36. Japan multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
37. India multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
38. India multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
39. India multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
40. Rest of Asia Pacific multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
41. Rest of Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
42. Rest of Asia Pacific multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
43. Latin America multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
44. Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
45. Latin America multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
46. Brazil multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
47. Brazil multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
48. Brazil multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
49. Rest of Latin America multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
50. Rest of Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
51. Rest of Latin America multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)
52. The Middle East & Africa multiplex biomarker imaging market revenue, by application, 2015 – 2024 (USD Million)
53. The Middle East & Africa multiplex biomarker imaging market revenue, by imaging techniques, 2015 – 2024 (USD Million)
54. The Middle East & Africa multiplex biomarker imaging market revenue, by end user, 2015 – 2024 (USD Million)

Methodology

Free Analysis

Multiplex biomarker imaging is a prominent technique mainly used for analysis of the correct disease and imaging its characteristics. Moreover, biomarkers are the biological markers used for the clinical studies to visualize the exact location and the current stage of the disease. The biomarker has significant use in the healthcare industry; they can be used alone or in combination as an indicator of biological processes and for evaluating & assessing their characteristics. Multiplex biomarker plays an important role in studying the complex biological system by providing analyzed expression of several biomarkers.

As per the World Health Organization, cardiovascular diseases are one of the causes of death worldwide. About 17.5 million people died because of cardiovascular disease in 2015 representing 31% of all global deaths. Additionally, as per the World Health Organization estimates, worldwide, there were 14 million new cancer cases in 2012 and 8.8 million deaths resulted due to cancer in 2015. Globally, approximately 1 in 6 deaths is because of cancer. Thus, multiplex biomarker imaging market has vast potential in terms of large patient pool and upsurge need for a prominent reagent for diagnosis and analysis. This is estimated to drive the multiplex biomarker imaging market services over the forecast period.

Global Multiplex Biomarker Imaging Market

The global multiplex biomarker imaging market is divided into its application, imaging techniques, and end-user. On the basis of the application, the market is divided into drug safety, oncology studies, and genetic characterization studies.

Based on the imaging techniques, the multiplex biomarker imaging market is categorized into immunofluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in the situ hybridization (FISH) assay, and toponome imaging System (TIS).

On the basis of the end-user, the multiplex biomarker imaging market is segregated as research institutes government & private, clinical labs, and pharmaceutical & biotechnology.
North America is anticipated to be the dominant region in the multiplex biomarker imaging market over the forecast period. Favorable government policies supporting the invasion of new and advanced biomarkers, development in the healthcare infrastructure, and research grant by the government and ruling authorities are expected to propel the market growth in this region. Europe is the second largest market followed by the Asia Pacific. The large healthcare industry due to the large population base in the Asia Pacific region, especially India, China, and Japan is the significant accelerating factor for the growth of the multiplex biomarker imaging market in this region. Therefore, Asia Pacific is anticipated to show the fastest CAGR growth during the forecast period whereas Latin America market is estimated to grow at a slow to moderate rate during the forecast period. The Middle East and Africa are also expected to cover the prominent market value share in the multiplex biomarker imaging market global market.

Some of the key players in multiplex biomarker imaging market include Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., and others.